Cyclacel Pharmaceuticals, Inc.(CYCCP) - 2025 Q4 - Annual Report
Cyclacel Pharmaceuticals, Inc.(US:CYCCP)2026-03-30 21:43UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 00-50626 BIO GREEN MED SOLUTION, INC. (Exact name of registrant as specified in its charter) Delaware 91-1707622 (State or Other Jurisdiction (I.R.S. Employer of Incorpora ...